Adding itraconazole to standard treatment for acute myeloid leukemia
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests whether adding the common antifungal drug itraconazole to standard leukemia treatment can help improve results for people with acute myeloid leukemia. It aims to see if the drug boosts the effectiveness of existing therapy to help fight the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been diagnosed with acute myeloid leukemia (a type of blood cancer)
- You are generally well enough to carry out daily activities (doctors rate this as 0, 1, or 2 on a scale of 0–4)
- You do not have chronic heart failure
- You do not have severe kidney problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a targeted antifungal medicine (aimed at PTX3) can better prevent serious fungal infections in adults with AML or a related bone marrow disease who will have very low neutrophils. It may help lower the risk of dangerous infections during intensive chemotherapy hospital stays.
This study tests whether adding a targeted pill (ivosidenib) to another maintenance drug (oral azacitidine) can help keep your leukemia in remission longer. It is for older adults with a specific gene change (IDH1) who have finished intensive chemotherapy.
This trial tests a maintenance treatment called 'ITIVA' for people with acute myeloid leukemia (AML) who have achieved remission after initial chemotherapy and consolidation therapy. The goal is to see if this treatment helps keep the leukemia from coming back.
This trial tests a combination of two chemotherapy drugs (idarubicin and cytarabine) plus a newer targeted medication (venetoclax) for people with newly diagnosed acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). The goal is to see if this treatment is effective and safe as an initial therapy.
This trial checks if a drug called itraconazole affects how your body processes another drug, HS-20093. It is for people with advanced solid tumors who have tried standard treatments or cannot tolerate them.
This trial tests a combination of antifungal medicines (liposomal amphotericin B and either isavuconazole or posaconazole) for people with blood cancers who develop a fungal infection despite taking preventive antifungal drugs. It aims to find a better treatment for these difficult infections.
Hear when a new Acute Myeloid Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.